Ewa Jassem

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer

Rafael Rosell, Marcin Skrzypski, Ewa Jassem et al. · PLoS ONE · 2007 · 211 citations · Full text

Medicine, Molecular Biology, Oncology +17

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

Toby M. Maher, Paul Ford, Kevin M. Brown et al. · JAMA · 2023 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu et al. · The Lancet · 2017 · 122 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +6

Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target

Mariëlle I. Gallegos Ruiz, Karijn Floor, Paul Roepman et al. · PLoS ONE · 2008 · 120 citations · Full text

Life Sciences, Genetics, Oncology +17